Essity AB stock (SE0009922164): Strategic review and growth strategy in focus

Essity AB has launched a strategic review of its consumer tissue business and outlined a profit-focused growth strategy at its Capital Markets Day, drawing attention from investors.

Essity AB has initiated a strategic review of its Consumer Tissue business area, a move that has put the Swedish hygiene and health group back in the spotlight for investors. The review, announced in early May 2026, covers a business area with about 13,000 employees and 29 production facilities, underscoring its scale within the group. The announcement coincides with Essity’s Capital Markets Day, where the company detailed a profit?focused growth strategy aimed at improving margins and cash flow over the medium term, according to Essity press release as of May 6, 2026.

Essity AB is a global hygiene and health company spun out of Svenska Cellulosa in June 2017, with leading positions in categories such as incontinence products, personal care, consumer tissue and professional hygiene. Its products span feminine care, baby care, toilet paper, facial tissues and other hygiene items sold under well?known brands in more than 150 countries. The company’s corporate headquarters are in Stockholm, Sweden, while its North American headquarters are in Philadelphia, Pennsylvania, giving it a direct presence in the US market, according to Essity Investor Relations as of May 9, 2026.

As of May 9, 2026, Essity AB Class B shares traded at 247.6 SEK on Nasdaq Stockholm, down about 3.1 SEK from the prior close, reflecting investor reactions to the strategic review and the broader outlook for the hygiene sector. The stock is listed on Nasdaq Stockholm under the ticker ESSITY B, with trading in Swedish krona, according to Essity IR page as of May 9, 2026. For US investors, the shares are accessible via international brokers that offer access to European exchanges, though there is no direct US listing.

By the editorial team – specialized in equity coverage.

At a glance

• Name: Essity AB
• Sector/industry: Health and hygiene / consumer goods
• Headquarters/country: Stockholm, Sweden
• Core markets: Europe, North America, Asia and other regions
• Key revenue drivers: Consumer tissue, incontinence products, personal care and professional hygiene
• Home exchange/listing venue: Nasdaq Stockholm (ESSITY B)
• Trading currency: Swedish krona (SEK)

Essity AB: core business model

Essity AB operates as a global hygiene and health group with a portfolio centered on everyday hygiene products used by consumers and institutions. The company’s business model combines branded consumer products with professional hygiene solutions sold to healthcare, hospitality and food service customers. Its product families include paper hygiene products such as toilet paper and tissues, incontinence products, feminine care, baby care and professional hygiene items, which together serve a broad base of households and organizations worldwide, according to MarketScreener profile as of May 9, 2026.

The company generates revenue through long?term relationships with retailers, distributors and institutional buyers, often under multi?year contracts. Essity’s strategy emphasizes innovation, sustainability and cost efficiency, with investments in product development, manufacturing optimization and digital tools to support customers. Its global footprint allows it to leverage scale in procurement and production while tailoring brands and formulations to regional preferences, particularly in Europe and North America, according to Essity IR overview as of May 9, 2026.

For US investors, Essity’s North American headquarters in Philadelphia highlights its exposure to the US economy and healthcare sector. The company supplies products to hospitals, clinics, long?term care facilities and retail chains across the United States, making it sensitive to trends in healthcare spending, consumer demand for premium hygiene products and regulatory developments in medical devices and personal care, according to Essity job posting as of May 9, 2026.

Main revenue and product drivers for Essity AB

Essity’s revenue is driven by several core product families, with paper hygiene products accounting for a significant share of net sales. Within this segment, consumer tissue products such as toilet paper, facial tissues and kitchen towels are key contributors, supported by professional hygiene offerings for institutions. The company also derives substantial revenue from incontinence products, which benefit from aging demographics and increased awareness of continence care, according to MarketScreener breakdown as of May 9, 2026.

Personal care and feminine care products, including tampons, pads and related hygiene items, represent another important revenue stream, particularly in developed markets where consumers are willing to pay for premium and sustainable options. Baby care products, such as diapers and wipes, add further diversification, with demand influenced by birth rates, household income levels and brand loyalty. Professional hygiene solutions for healthcare and food service customers provide more stable, contract?based revenue, helping to balance the cyclicality of consumer?driven segments, according to Essity IR description as of May 9, 2026.

The strategic review of the Consumer Tissue business area, announced in May 2026, signals that management is scrutinizing this segment’s profitability and growth potential. With about 13,000 employees and 29 production facilities tied to consumer tissue, any structural changes—such as portfolio adjustments, capacity rationalization or potential divestments—could reshape the company’s earnings profile and capital allocation over time, according to Essity press release as of May 6, 2026.

Industry trends and competitive position

The global hygiene and tissue sector is characterized by intense competition, price sensitivity and ongoing pressure to reduce environmental impact. Major competitors include other multinational hygiene groups as well as regional players that focus on local brands and cost?efficient production. Essity positions itself as a leader in innovation and sustainability, emphasizing product quality, brand strength and environmental certifications to differentiate from lower?cost rivals, according to Essity IR materials as of May 9, 2026.

Regulatory and consumer trends favor products with lower environmental footprints, such as recycled fibers, reduced packaging and water?saving manufacturing processes. Essity has committed to sustainability targets, including reducing greenhouse gas emissions and increasing the share of renewable materials in its products, which aligns with broader European and US regulatory directions. These efforts can support brand loyalty and access to environmentally conscious retailers and institutional buyers, according to Essity sustainability disclosures as of May 9, 2026.

For US investors, Essity’s competitive position in the North American market is relevant because of the size of the US healthcare and consumer goods sectors. The company’s presence in Philadelphia and its supply relationships with US healthcare providers and retailers mean that its performance is linked to US economic conditions, healthcare policy and consumer spending patterns, according to Essity job posting as of May 9, 2026.

Conclusion

Essity AB is a global hygiene and health company with a diversified portfolio spanning consumer tissue, incontinence products, personal care and professional hygiene. The recent strategic review of its Consumer Tissue business area and the profit?focused growth strategy outlined at the Capital Markets Day highlight management’s focus on improving margins and cash flow, which could influence the company’s valuation and capital allocation over time, according to Essity press release as of May 6, 2026.

For US investors, Essity offers exposure to the European and global hygiene sector through a company with a significant presence in North America and a track record of innovation and sustainability initiatives. However, the stock is listed on Nasdaq Stockholm and trades in Swedish krona, which introduces currency and market?access considerations. Investors should weigh the company’s competitive position, exposure to healthcare and consumer trends, and the potential outcomes of the strategic review against broader macroeconomic and sector risks, according to Essity IR overview as of May 9, 2026.

This article does not constitute investment advice. Stocks are volatile financial instruments and past performance is not indicative of future results.